Welcome to our website!

Product Catalog

Rapid Product Index

Recommended Products

Friend Links

  • 2-Amino-6-(trifluoromethoxy)benzo[d]thiazole  1744-22-5
Name:2-Amino-6-(trifluoromethoxy)benzo[d]thiazole 1744-22-5
CAS No:1744-22-5

PRODUCT DESCRIPTION


Description

Riluzole (Rilutek, Teglutik) is a drug used to treat amyotrophic lateral sclerosis. These are marketed by Sanofi Pharmaceuticals and Martindale Pharma respectively. Riluzole delays the onset of ventilator-dependence or tracheostomy in selected patients and may increase survival by approximately two to three months.
Riluzole is available in tablet (Rilutek, riluzole) and liquid (Teglutik) form. The liquid formulation may be more suitable for patients with swallowing difficulties.

Basic Info

Chemical Name 2-Amino-6-(trifluoromethoxy)benzo[d]thiazole
Synonyms

6-(trifluoromethoxy)-1,3-benzothiazol-2-amine;2-Amino-6-(trifluoromethoxy)benzothiazole;6-(Trifluoromethoxy)benzo[d]thiazol-2-amine;

CAS No. 1744-22-5
Molecular Formula C8H5F3N2OS
Molecular Weight 234.19800
PSA 76.38000
LogP 3.35830

Properties

Appearance & Physical State Powder.
Density 1.572 g/cm3
Boiling Point 296.3ºC at 760 mmHg
Melting Point 116-118ºC
Flash Point 133ºC
Storage Condition Store at room temperature in a tightly sealed container.
Vapor Pressure 0.00145mmHg at 25°C

Safety Info

Safety Statements S45
HS Code 2934999090
RIDADR UN 2811
Risk Statements R25
Hazard Codes T

RELATED PRODUCTS